CiteULike: guhjy's Rossing:K [13 articles]

	Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised crossover trial. [My Copy] Diabetologia, Vol. 52, No. 1. (January 2009), pp. 46-49. by K. J. Schjoedt, A. S. Astrup, F. Persson, et al.E. Frandsen, F. Boomsma, K. Rossing, L. Tarnow, P. Rossing, H. H. Parving posted to renoprotection acei dose rct uae by guhjy on 2009-03-21 01:22:33 as
	Optimal dose of candesartan for renoprotection in type 2 diabetic patients with nephropathy: a double-blind randomized cross-over study. [My Copy] Diabetes care, Vol. 26, No. 1. (January 2003), pp. 150-155. by K. Rossing, P. K. Christensen, B. V. Hansen, B. Carstensen, H. H. Parving posted to renoprotection arb dn dose rct by guhjy on 2009-03-08 15:38:19 as
	Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria. [My Copy] Kidney international, Vol. 68, No. 3. (September 2005), pp. 1190-1198. by K. Rossing, K. J. Schjoedt, B. R. Jensen, F. Boomsma, H. H. Parving posted to renoprotection arb dm dose rct uae by guhjy on 2009-02-25 07:10:46 as
	Quantitative Urinary Proteome Analysis for Biomarker Evaluation in Chronic Kidney Disease. [My Copy] Journal of proteome research (14 November 2008) by Justyna Jantos-Siwy, Eric Schiffer, Korbinian Brand, et al.Gerhard Schumann, Kasper Rossing, Christian Delles, Harald Mischak, Jochen Metzger posted to ce ckd ms proteomics urine by guhjy on 2009-01-12 02:52:37 as
	Clinical proteomics: A need to define the field and to begin to set adequate standards [My Copy] PROTEOMICS - Clinical Applications, Vol. 1, No. 2. (2007), pp. 148-156. by Harald Mischak, Rolf Apweiler, Rosamonde E. Banks, et al.Mark Conaway, Joshua Coon, Anna Dominiczak, Jochen H. H. Ehrich, Danilo Fliser, Mark Girolami, Henning Hermjakob, Denis Hochstrasser, Joachim Jankowski, Bruce A. Julian, Walter Kolch, Ziad A. Massy, Christian Neusuess, Jan Novak, Karlheinz Peter, Kasper Rossing, Joost Schanstra, O. John Semmes, Dan Theodorescu, Visith Thongboonkerd, Eva M. Weissinger, Jennifer E. Van Eyk, Tadashi Yamamoto posted to proteomics by guhjy on 2008-11-09 09:13:01 as along with 1 person wilbur
	Impact of diabetic nephropathy and angiotensin II receptor blockade on urinary polypeptide patterns. [My Copy] Kidney international, Vol. 68, No. 1. (July 2005), pp. 193-205. by K. Rossing, H. Mischak, H. H. Parving, et al.P. K. Christensen, M. Walden, M. Hillmann, T. Kaiser posted to aii dn proteomics urine by guhjy on 2008-11-08 15:25:39 as
	CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics [My Copy] PROTEOMICS - CLINICAL APPLICATIONS, Vol. 2, No. 7-8. (2008), pp. 964-973. by Joshua J. Coon, Petra Zürbig, Mohammed Dakna, et al.Anna F. Dominiczak, Stéphane Decramer, Danilo Fliser, Moritz Frommberger, Igor Golovko, David M. Good, Stefan Herget-Rosenthal, Joachim Jankowski, Bruce A. Julian, Markus Kellmann, Walter Kolch, Ziad Massy, Jan Novak, Kasper Rossing, Joost P. Schanstra, Eric Schiffer, Dan Theodorescu, Raymond Vanholder, Eva M. Weissinger, Harald Mischak, Philippe Schmitt-Kopplin posted to ce-ms proteomics urine by guhjy on 2008-09-01 05:44:46 as
	The urinary proteome in diabetes and diabetes-associated complications: New ways to assess disease progression and evaluate therapy [My Copy] PROTEOMICS - CLINICAL APPLICATIONS, Vol. 2, No. 7-8. (2008), pp. 997-1007. by Kasper Rossing, Harald Mischak, Peter Rossing, Joost P. Schanstra, Alex Wiseman, David M. Maahs posted to dn proteomics urine by guhjy on 2008-09-01 05:44:23 as
	Urinary Proteomics in Diabetes and CKD [My Copy] J Am Soc Nephrol, Vol. 19, No. 7. (1 July 2008), pp. 1283-1290. by Kasper Rossing, Harald Mischak, Mohammed Dakna, et al.Petra Zurbig, Jan Novak, Bruce A. Julian, David M. Good, Joshua J. Coon, Lise Tarnow, Peter Rossing, on behalf of the PREDICTIONS Network posted to urine proteomics dn by guhjy on 2008-05-23 14:59:39 as
	Anaemia in diabetes: Is there a rationale to TREAT? [My Copy] Diabetologia, Vol. 49, No. 6. (June 2006), pp. 1151-1157. by M. C. Thomas, M. E. Cooper, K. Rossing, H. H. Parving posted to no-tag by guhjy on 2007-09-19 02:03:20 as
	Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy. [My Copy] Kidney Int, Vol. 70, No. 3. (August 2006), pp. 536-542. by K. J. Schjoedt, K. Rossing, T. R. Juhl, et al.F. Boomsma, L. Tarnow, P. Rossing, H. H. Parving posted to aldosterone dn by guhjy on 2007-08-12 03:31:44 as
	Progression of nephropathy in type 2 diabetic patients. [My Copy] Kidney international, Vol. 66, No. 4. (October 2004), pp. 1596-1605. by Kasper Rossing, Per K. Christensen, Peter Hovind, Lise Tarnow, Peter Rossing, Hans-Henrik H. Parving posted to doubling dn creatinine by guhjy on 2007-08-03 11:43:20 as
	Progression and remission of nephropathy in type 2 diabetes: new strategies of treatment and monitoring. [My Copy] Dan Med Bull, Vol. 54, No. 2. (May 2007), pp. 79-98. by K. Rossing posted to dn review by guhjy on 2007-07-24 11:40:45 as

guhjy's Rossing:K [13 articles] Export Sort

guhjy's tags

ckd	1738
rct	1203
dn	1146
dm	1046
cancer	1044
ma	979
cv	926
hd	859
tgfb	841
snp	772
ros	661
bp	644
meta-analysis	516
kidney	507
uae	501
mouse	493
stats	480
software	463
mirna	450
pt	449
genetics	449
proteomics	412
mortality	408
rat	390
fbl	379
tw	373
inflammation	371
proteinuria	356
pcr	353
akt	346
mtor	346
mc	343
1	340
db	337
acei	334
gdl	331
irs	326
test	325
inhibitor	324
method	323
urine	320
arb	316
apoptosis	314
aging	311
age	311
ms	310
hcv	304
aii	299
r	294
biomarker	287
hg	285
ppi	282
bias	277
pi3k	276
bayes	275
gwa	270
aki	269
s6k	262
emt	260
nutrition	255
rnai	249
egfr	249
p53	243
ub	242
obesity	236
fibrosis	236
erk	232
cox	229
smad	228
drug	225
pbmc	223
hcc	216
metab	214
hypoxia	212
gn	210
nfkb	205
herb	204
stz	196
collagen	192
albumin	189
lc	187
hif	184
longitudinal	179
pubmed	179
lmm	178
pkc	175
gfr	174
p38	173
ua	170
epigenetics	169
bioinf	166
japan	165
power	163
cea	163
rage	162
gender	162
dna-damage	161
lead	160
cadmium	158
ref	154
genomics	151
vitamin-d	148
ctgf	147
stata	147
liver	146
book	146
network	146
company	144
screening	137
diet	136
rt	136
phosphorylation	135
mt	133
seq	133
kinase	128
go	128
protein	127
pathway	127
cell-cycle	126
no	126
esrd	124
systems-biology	124
insulin	122
lipid	118
creatinine	117
statin	117
proliferation	113
senescence	109
mapk	109
stat	106
podocyte	106
fish	104
tnf	104
regression	103
gfr-formula	102
cad	102
pd	102
case-control	102
hypertrophy	101
imputation	101
nox	100
multiplicity	100
imaging	100
rx	99
p21	98
observational	98
sirt	97
methylation	96
pediatric	96
pparg	96
cloning	96
plasmid	96
at1	95
recurrent	94
betel	93
blood	93
chf	91
src	90
nhanes	90
website	89
anemia	88
phenotype	88
immunity	88
ko	88
diagnosis	87
toxicology	86
review	86
lr	86
uti	85
gene-therapy	84
epo	84
ebm	84
cytokine	84
china	83
environment	82
ca	81
nonp	81
oat	81
cachexia	81
p	81
hapmap	80
gout	78
autophagy	78
primer	78
qms	77
signaling	75
egf	75
missing	73
promoter	73
ace	73
eif	73
cox2	73
stone	72
lpd	72
surrogate	72
eqtl	72
gene-list	72
gpcr	72
mv	71
p-value	71
col4	71
ampk	71
4ebp	71
salt	70
phd	69
foxo	69
jnk	69
mgo	68
glycemia	66
uncertainty	66
hts	65
chinese	65
pe	65
uuo	65
mirna-target	65
normalization	65
tin	65
shc	64
ifn	64
association	64
enddysf	63
yeast	63
acid-base	63
2dge	63
causation	63
pla2	63
hsp	63
smoking	62
llcpk1	62
simulation	62
nrk49f	62
translation	62
me	62
avf	61
oglcnac	61
pdgf	61
confounding	61
ptm	61
mmp	60
outcome	60
infection	60
change	60
sas	60
melamine	60
pai1	59
oral	59
crp	59
cost	59
alcohol	58
hk2	58
achr	57
rho	57
pls	57
urate-transporter	57
vegf	57
model-selection	57
robust	57
fluorescence	57
aceiarb	56
rapamycin	56
semantic	56
calibration	56
competing-risk	55
goldstd	55
ratio	55
ace2	55
ncrna	55
cyclin-d1	54
workflow	54
function	54
iron	54
ckd-progression	54
stem-cell	54
bone	54
estrogen	54
hsc	53
dipstick	53
renoprotection	53
pld	53
k	53
std	53
dimerization	52
il6	52
tf	52
histone	52
atm	52
qc	52
fgf	52
ab	51
normoalbuminuria	51
epidemiology	51
hdac	51
pth	51
lod	51
matlab	50
risk-ratio	50
hepatocyte	50
arsenic	50
p27	50
graph	50
adpkd	50
reasoning	50
mercury	50
wnt	50
klotho	49
epistasis	49
gene-environment	49
antibiotics	49
core-curriculum	48
ngal	48
ukm	48
pdk	48
irs1	48
ffpe	48
endothelium	48
breakpoint	48
nrk52e	48
spot-urine	47
pooling	47
joint-model	47
mtorc1	47
aspirin	46
ras	46
hgf	46
cystatin	46
dub	46
aldosterone	46
protein-microarray	46
fdr	46
prevention	45
semip	45
fgf23	45
metal	45
biosensor	45
writing	45
dbdb	45
diuretics	44
interaction	44
ecm	44
tgfbr	44
metformin	44
variability	44
er-stress	44
ancova	44
enos	44
mesangial	44
ccb	44
sumo	44
klf	43
bia	43
sle	43
cnv	43
na	43
design	43
asia	42
bmi	42
agreement	42
good	42
roc	42
icu	42
stroke	42
fuzzy	41
qtl	41
catenin	41
vsmc	41
tlr	40
hyperfiltration	40
fibronectin	40
sage	40
alignment	40
gene-targeting	40
risk	40
wga	40
ap1	39
angiogenesis	39
urinalysis	39
dry-bw	39
rca	39
protein-complex	39
igf	39
tea	38
igan	38
myc	38
antisense	38
rvh	38
omics	38
gsk3	37
gsk	37
propensity	37
emr	37
glut	37
adh	37
fabp	37
haplotype	37
bh4	37
hematuria	37
rsk	37
mtorc2	36
snx	36
adenosine	36
proteasome	36
cardiorenal	36
megalin	36
web20	36
il1	36
animal	36
inflammasome	36
s100b	36
chemogenomics	35
sp1	35
coffee	35
candidate-gene	35
exercise	35
annotation	35
subgroup	35
cre	35
adduct	35
reverse-epidemiology	35
threshold	35
calcification	35
nephrotoxicity	34
msm	34
sglt	34
sepsis	34
creb	34
attrition	34
pathology	34
cross-species	34
effect-size	34
pka	33
ecology	33
sarcopenia	33
zeb	33
rtk	33
bmp	33
cage	33
ns	33
integrin	33
affy	32
ai	32
addgene	32
pp2a	32
steroid	32
et	32
set	32
end-point	32
text-mining	32
aa	32
browser	32
zfn	32
fc	32
macrophage	32
orbitrap	32
gllamm	31
frailty	31
family	31
silac	31
agt	31
heritability	31
hospitalization	31
emsa	31
transactivation	31
igf1	31
abp	31
blast	31
risk-difference	31
mw	30
membrane-protein	30
reporter	30
transporter	30
notch	30
grn	30
pten	30
carcinogen	30
s100	30
cr	30
knockout	30
staging	30
geo	30
ub-ligase	29
3	29
perindopril	29
nicotinic	29
validation	29
nutrient	29
virus	29
human	29
sgk	29
extraction	29
renin	29
pharmacogenetics	28
race	28
mutagenesis	28
time-dependent	28
acetylation	28
gee	28
hplc	28
thesis	28
scaling	28